Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85651-85700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05315661
The Safety and The Efficacy Evaluation of ET-STEM in Patients With Frontotemporal Dementia
PHASE1
Active, not recruiting
12 participants
Started: Jul 6, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05252429
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell Carcinoma
PHASE2
Active, not recruiting
27 participants
Started: Jul 6, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT05821140
Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health
NA
Recruiting
112 participants
Started: Jul 5, 2022 · Completed: Feb 29, 2032
4 conditions
2 sponsors
1 location
NCT05301816
PDN Post Market, Multicenter, Prospective, Global Clinical Study
NA
Recruiting
497 participants
Started: Jul 5, 2022 · Completed: Oct 31, 2028
1 condition
1 sponsor
8 locations
NCT04324944
Adapting and Examining Collaborative Decision Skills Training Among Veterans With Serious Mental Illness
NA
Active, not recruiting
39 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06053697
Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies?
N/A
Active, not recruiting
120 participants
Started: Jul 5, 2022 · Completed: Apr 30, 2026
8 conditions
3 sponsors
1 location
NCT05214105
The Predictive Capacity of Machine Learning Models for Progressive Kidney Disease in Individuals With Sickle Cell Anemia
N/A
Recruiting
400 participants
Started: Jul 5, 2022 · Completed: Jan 31, 2026
2 conditions
7 sponsors
3 locations
NCT05393648
Bipolar Efficacy Biomarkers for rTMS
NA
Active, not recruiting
60 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05876208
Increased Home-based Physical Therapy Adherence Using BAND Connect's VirtuaCare™ Platform
NA
Recruiting
60 participants
Started: Jul 5, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05096260
Getting to Yes, Michigan! (G2YMI)
NA
Active, not recruiting
700 participants
Started: Jul 5, 2022 · Completed: Mar 11, 2026
2 conditions
3 sponsors
1 location
NCT05128903
Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study
PHASE2
Active, not recruiting
22 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06546332
Post Market Clinical Follow-Up KeriFuse®
N/A
Active, not recruiting
97 participants
Started: Jul 5, 2022 · Completed: Mar 31, 2027
1 condition
1 sponsor
6 locations
NCT05135611
The Efficacy of the 4-channel Sequential NMES for the Treatment of Sleep Apnea
NA
Active, not recruiting
11 participants
Started: Jul 5, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT05422508
Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination
PHASE2
Recruiting
230 participants
Started: Jul 5, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT05203172
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials
PHASE4
Recruiting
46 participants
Started: Jul 5, 2022 · Completed: Jul 31, 2029
1 condition
1 sponsor
63 locations
NCT05389267
Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.
PHASE1/PHASE2
Active, not recruiting
120 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT05415215
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer
PHASE3
Active, not recruiting
347 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
45 locations
NCT05984485
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
PHASE3
Recruiting
766 participants
Started: Jul 5, 2022 · Completed: Jul 31, 2028
1 condition
1 sponsor
6 locations
NCT05426733
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
PHASE3
Enrolling by invitation
180 participants
Started: Jul 5, 2022 · Completed: Aug 31, 2028
1 condition
1 sponsor
30 locations
NCT05344573
Optimizing Pulsatility During Cardiopulmonary Bypass
N/A
Recruiting
66 participants
Started: Jul 5, 2022 · Completed: Jul 1, 2025
2 conditions
2 sponsors
1 location
NCT05791786
The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)
N/A
Recruiting
400 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2031
1 condition
2 sponsors
1 location
NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
PHASE1
Recruiting
156 participants
Started: Jul 5, 2022 · Completed: Sep 28, 2028
4 conditions
1 sponsor
40 locations
NCT05465122
CREST-2 Long-term Observational Extension Study
N/A
Enrolling by invitation
2,480 participants
Started: Jul 5, 2022 · Completed: Feb 28, 2026
1 condition
5 sponsors
64 locations
NCT05238922
Study of INCB123667 in Subjects With Advanced Solid Tumors
PHASE1
Recruiting
604 participants
Started: Jul 5, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
43 locations
NCT05379634
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
PHASE2
Active, not recruiting
36 participants
Started: Jul 5, 2022 · Completed: Sep 16, 2026
1 condition
1 sponsor
57 locations
NCT05439226
Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabetes With Nonalcoholic Fatty Liver Disease
NA
Recruiting
120 participants
Started: Jul 5, 2022 · Completed: Jun 5, 2026
1 condition
1 sponsor
3 locations
NCT04936282
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)
PHASE4
Recruiting
80 participants
Started: Jul 5, 2022 · Completed: Jun 30, 2024
1 condition
1 sponsor
4 locations
NCT05435612
Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation
NA
Recruiting
30 participants
Started: Jul 5, 2022 · Completed: Jul 1, 2026
1 condition
1 sponsor
1 location
NCT07164235
Spondylodiscitis: a Retrospective Observational Study.
N/A
Active, not recruiting
137 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06285526
Glycocalyx Monitoring in Major Abdominal Surgery
N/A
Recruiting
100 participants
Started: Jul 5, 2022 · Completed: Jan 5, 2025
1 condition
1 sponsor
1 location
NCT05400980
Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath
NA
Active, not recruiting
240 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT05330507
Prospective, Observational Study of Wellinks Effect on COPD Hospital Readmissions
N/A
Recruiting
150 participants
Started: Jul 5, 2022 · Completed: Jun 30, 2024
5 conditions
2 sponsors
1 location
NCT05300269
SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer
PHASE2
Recruiting
73 participants
Started: Jul 5, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT05377840
Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of Anxiety and/or Depression in Inflammatory Bowel Disease (IBD)
NA
Recruiting
152 participants
Started: Jul 5, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT05016804
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis
PHASE1
Recruiting
20 participants
Started: Jul 4, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
2 locations
NCT05139238
Postpartum Hypertension Study
PHASE4
Recruiting
104 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2027
4 conditions
1 sponsor
1 location
NCT05004896
Ketamine for Treatment-Resistant Bipolar Disorder
PHASE2
Recruiting
72 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
3 locations
NCT05176444
Managing the Needs of Care Home Residents With Dementia Through a Music Therapy Intervention
NA
Active, not recruiting
84 participants
Started: Jul 4, 2022 · Completed: Jun 30, 2024
2 conditions
3 sponsors
11 locations
NCT05413616
The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional Training Program on Physical Performance in Hospitalized Older Patients, Compared to Usual Care
NA
Recruiting
136 participants
Started: Jul 4, 2022 · Completed: Jul 1, 2027
1 condition
1 sponsor
1 location
NCT06306300
Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil)
PHASE4
Recruiting
30,000 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT05393193
POC HIV Testing and Early DTG Use for Infants
PHASE4
Active, not recruiting
900 participants
Started: Jul 4, 2022 · Completed: Aug 31, 2026
1 condition
5 sponsors
1 location
NCT05494983
Pain, Sleep and Gut Microbiota
NA
Recruiting
140 participants
Started: Jul 4, 2022 · Completed: Jan 4, 2026
4 conditions
1 sponsor
1 location
NCT06095375
Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients
PHASE1
Active, not recruiting
36 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT05466292
Evaluating a Clinical Ethics Committee (CEC) Implementation Process
N/A
Active, not recruiting
20 participants
Started: Jul 4, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT06765850
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
N/A
Recruiting
3,000 participants
Started: Jul 4, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT05415072
A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Jul 4, 2022 · Completed: Oct 1, 2027
1 condition
1 sponsor
11 locations
NCT05442840
Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes
NA
Active, not recruiting
60 participants
Started: Jul 4, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05527262
Intensive Upper Limb Training in Chronic Stroke
PHASE2
Recruiting
105 participants
Started: Jul 4, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05453019
Effects of CI on Tinnitus and Its Symptoms
NA
Recruiting
200 participants
Started: Jul 4, 2022 · Completed: Jul 1, 2027
1 condition
1 sponsor
1 location
NCT05468268
Noninvasive Brain Stimulation for pAD
NA
Active, not recruiting
40 participants
Started: Jul 4, 2022 · Completed: Dec 4, 2025
1 condition
4 sponsors
1 location
Previous
1
More pages
1711
1712
1713
1714
1715
1716
1717
More pages
2369
Next